Germline editing in humans is a line we shouldn't cross yet, despite CRISPR's success in treating sickle cell disease. We've seen how quickly new technologies can outpace oversight, and the risks of unintended consequences in future generations are simply too high to justify. Even with promising clinical results, the long-term effects on embryos are still largely unknown, and rushing ahead could create irreversible problems. That's why I'd vote NO on allowing heritable genetic modifications right now.